Biocon inches up on getting USFDA’s nod for Liraglutide Injection
Mumbai, February 25 (Udaipur Kiran): Biocon is currently trading at Rs. 391.40, up by 1.05 points or 0.27% from its previous closing of Rs. 390.35 on the BSE. The scrip opened at Rs. 392.90 and has touched a high and low of Rs. 395.00 and Rs. 390.30 respectively. So far 28172 shares were traded on … Read more
